HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elsevier acquires Windhover

This article was originally published in The Rose Sheet

Executive Summary

Elsevier, the parent company of F-D-C Reports, builds upon its array of news and business intelligence services for drug and medical device industries with acquisition of Windhover Information, announced March 10. Elsevier says deal fits with its goal of increasing the "depth and breadth" of offerings that enable informed planning and strategic management. F-D-C Reports publications include "The Rose Sheet," "The Tan Sheet" and "The Pink Sheet," among others. Windhover's businesses include Strategic Transactions Database, a number of drug and device partnering and strategy conferences, and journals IN VIVO and RPM Report. Windhover will operate within Elsevier's Pharma Business Intelligence Unit, which includes Inteleos drug development database as well as F-D-C Reports...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS015302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel